A Small-Molecule Inhibitor of Hepatitis C Virus Infectivity

One of the most challenging goals of hepatitis C virus (HCV) research is to develop well-tolerated regimens with high cure rates across a variety of patient populations. Such a regimen will likely require a combination of at least two distinct direct-acting antivirals (DAAs). Combining two or more D...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Bush, Caroline O., Pokrovskii, Maria V., Saito, Roland, Morganelli, Philip, Canales, Eda, Clarke, Michael O., Lazerwith, Scott E., Golde, Justin, Reid, Brian G., Babaoglu, Kerim, Pagratis, Nikos, Zhong, Weidong, Delaney, William E., Paulson, Matthew S., Beran, Rudolf K. F.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Microbiology 2014
Témata:
Antiviral Agents
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3910743/
https://ncbi.nlm.nih.gov/pubmed/24165192
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02083-13
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky